![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/30/2921007/28255/en/Evoke-Pharma-Inc-Announces-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2024/06/17/2899668/28255/en/Evoke-Pharma-Reports-Commercial-Strategy-Progress-Positive-Momentum-for-GIMOTI.html
https://www.globenewswire.com/news-release/2024/05/16/2883857/28255/en/Evoke-Pharma-to-Present-Additional-GIMOTI-Healthcare-Utilization-Data-Focused-on-Gastroparesis-Care-Insights-in-Women-at-2024-Digestive-Disease-Week-DDW-Conference.html
https://www.globenewswire.com/news-release/2024/05/14/2881922/28255/en/Evoke-Pharma-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/17/2864546/28255/en/Evoke-Pharma-to-Host-Virtual-Key-Opinion-Leader-KOL-Webinar-on-the-Evolving-Landscape-of-Gastroparesis-GIMOTI-Hospitalizations-and-GLP-1-Medications.html
https://www.globenewswire.com/news-release/2024/03/21/2850636/28255/en/Evoke-Pharma-Announces-Senior-Leadership-Transition-with-Promotion-of-Matthew-J-D-Onofrio-to-Chief-Executive-Officer.html
https://www.globenewswire.com//news-release/2024/03/14/2846691/28255/en/Evoke-Pharma-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/07/2842763/28255/en/Evoke-Pharma-to-Report-Fourth-Quarter-and-Full-Year-2023-Results-on-March-14-2024.html
https://www.globenewswire.com//news-release/2024/02/14/2828998/28255/en/Evoke-Pharma-Announces-Closing-of-7-5-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/02/09/2826743/28255/en/Evoke-Pharma-Announces-Pricing-of-Underwritten-Public-Offering-of-up-to-30-Million.html